From June 19-22, 2017, thousands of the world’s leading biopharmaceuticals descended on San Diego at BIO. Rabin Martin was on the ground and brings you key insights from this year's conference on issues of access and commercialization in emerging markets, innovative financing models to support vaccine development, patient perspectives within value-based pricing schemes and biopharma’s response to the surge in antimicrobial resistance.
Update, 5/17/17: Now featuring an updated calendar of side events.
Attended by stakeholders from industry, governments, NGOs and others, WHA provides a forum for multilateral dialogue to advance health policies to reduce the burden of diseases and drive resources around key health issues. Planning to attend? Check out our guide to key side events.